Lonsurf is a prescription medication used to treat advanced colorectal cancer. It is a single product containing trifluridine and tipiracil. Trifluridine belongs to a group of drugs called nucleoside metabolic inhibitor. Tipiracil belongs to a group of drugs called thymidine phosphorylase inhibitor. Together these work to stop the growth and spread of cancer cells. To buy Lonsurf or to know its price contact 3S Corporation.
Manufacturer : Taiho Pharmaceuticals Company Limited
Strengths available : 15mg/6.14mg* & 20mg/8.19mg*
Form : Tablets
Dosage : Usual Adult Dose for Colorectal Cancer:-Initial dose: 35 mg/m2 orally twice a day on Days 1 through 5 and Days 8 through 12 of each 28-day cycle (based on trifluridine component)
-Maximum dose: 80 mg per dose (based on trifluridine component)
-Duration of therapy: Until disease progression or unacceptable toxicity
Storage : Store at room temperature 15°C to 30°C
Is the medicine US FDA approved : Yes
Date of Approval : September 22, 2015
Common side effects are infection, anemia, asthenia, diarrhea, fatigue, fever, nausea, neutropenia, thrombocytopenia, vomiting, and decreased appetite. Other side effects include: alopecia, and dysgeusia.
Bottle of 40 tablets and 60 tablets